Suraj Kalia
Stock Analyst at Oppenheimer
(3.64)
# 723
Out of 4,843 analysts
78
Total ratings
46.27%
Success rate
8.15%
Average return
Main Sectors:
Stocks Rated by Suraj Kalia
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TMDX TransMedics Group | Maintains: Outperform | $125 → $130 | $127.12 | +2.27% | 10 | May 9, 2025 | |
| ATRC AtriCure | Maintains: Outperform | $36 → $45 | $34.57 | +30.17% | 7 | Feb 13, 2025 | |
| VREX Varex Imaging | Maintains: Outperform | $30 → $23 | $7.67 | +199.87% | 6 | Feb 7, 2025 | |
| IRTC iRhythm Technologies | Maintains: Outperform | $105 → $120 | $140.87 | -14.82% | 5 | Jan 8, 2025 | |
| AORT Artivion | Maintains: Outperform | $30 → $32 | $29.65 | +7.94% | 3 | Nov 8, 2024 | |
| LMAT LeMaitre Vascular | Reiterates: Outperform | $90 → $93 | $82.53 | +12.69% | 2 | Nov 1, 2024 | |
| ABT Abbott Laboratories | Initiates: Outperform | $130 | $133.58 | -2.68% | 1 | Oct 8, 2024 | |
| TLSI TriSalus Life Sciences | Initiates: Outperform | $10 | $5.44 | +83.99% | 1 | Sep 16, 2024 | |
| EW Edwards Lifesciences | Maintains: Outperform | $90 | $78.22 | +15.06% | 5 | Sep 12, 2024 | |
| NYXH Nyxoah | Maintains: Outperform | $15 → $13 | $7.75 | +67.74% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $135 | $118.76 | +13.67% | 1 | Jul 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Perform | n/a | $244.79 | - | 6 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $24 → $30 | $9.88 | +203.64% | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $16 → $10 | $0.18 | +5,382.46% | 1 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $97 | $70.54 | +37.51% | 1 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $21.85 | +28.15% | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $4.5 | $2.40 | +87.50% | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $2.67 | +499.25% | 1 | Sep 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $552.34 | - | 3 | Apr 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $660 | $2.43 | +27,060.49% | 2 | Nov 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Perform | n/a | $138.13 | - | 2 | Nov 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Perform | n/a | $5.12 | - | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $30.50 | +227.87% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Market Perform | n/a | $85.80 | - | 5 | Sep 12, 2018 |
TransMedics Group
May 9, 2025
Maintains: Outperform
Price Target: $125 → $130
Current: $127.12
Upside: +2.27%
AtriCure
Feb 13, 2025
Maintains: Outperform
Price Target: $36 → $45
Current: $34.57
Upside: +30.17%
Varex Imaging
Feb 7, 2025
Maintains: Outperform
Price Target: $30 → $23
Current: $7.67
Upside: +199.87%
iRhythm Technologies
Jan 8, 2025
Maintains: Outperform
Price Target: $105 → $120
Current: $140.87
Upside: -14.82%
Artivion
Nov 8, 2024
Maintains: Outperform
Price Target: $30 → $32
Current: $29.65
Upside: +7.94%
LeMaitre Vascular
Nov 1, 2024
Reiterates: Outperform
Price Target: $90 → $93
Current: $82.53
Upside: +12.69%
Abbott Laboratories
Oct 8, 2024
Initiates: Outperform
Price Target: $130
Current: $133.58
Upside: -2.68%
TriSalus Life Sciences
Sep 16, 2024
Initiates: Outperform
Price Target: $10
Current: $5.44
Upside: +83.99%
Edwards Lifesciences
Sep 12, 2024
Maintains: Outperform
Price Target: $90
Current: $78.22
Upside: +15.06%
Nyxoah
Aug 7, 2024
Maintains: Outperform
Price Target: $15 → $13
Current: $7.75
Upside: +67.74%
Jul 16, 2024
Initiates: Outperform
Price Target: $135
Current: $118.76
Upside: +13.67%
Jun 25, 2024
Downgrades: Perform
Price Target: n/a
Current: $244.79
Upside: -
Aug 8, 2023
Maintains: Outperform
Price Target: $24 → $30
Current: $9.88
Upside: +203.64%
Jun 23, 2023
Maintains: Outperform
Price Target: $16 → $10
Current: $0.18
Upside: +5,382.46%
May 16, 2023
Initiates: Outperform
Price Target: $97
Current: $70.54
Upside: +37.51%
Mar 6, 2023
Reiterates: Outperform
Price Target: $28
Current: $21.85
Upside: +28.15%
Nov 29, 2022
Initiates: Outperform
Price Target: $4.5
Current: $2.40
Upside: +87.50%
Sep 24, 2021
Initiates: Outperform
Price Target: $16
Current: $2.67
Upside: +499.25%
Apr 21, 2021
Upgrades: Perform
Price Target: n/a
Current: $552.34
Upside: -
Nov 17, 2020
Upgrades: Outperform
Price Target: $660
Current: $2.43
Upside: +27,060.49%
Nov 3, 2020
Upgrades: Perform
Price Target: n/a
Current: $138.13
Upside: -
Sep 15, 2020
Initiates: Perform
Price Target: n/a
Current: $5.12
Upside: -
Jun 24, 2020
Initiates: Outperform
Price Target: $100
Current: $30.50
Upside: +227.87%
Sep 12, 2018
Upgrades: Market Perform
Price Target: n/a
Current: $85.80
Upside: -